126 related articles for article (PubMed ID: 2541513)
1. Pathology of high-dose intraarterial BCNU.
Kleinschmidt-DeMasters BK; Geier JM
Surg Neurol; 1989 Jun; 31(6):435-43. PubMed ID: 2541513
[TBL] [Abstract][Full Text] [Related]
2. Pre-irradiation internal carotid artery BCNU in treatment of glioblastoma multiforme.
Bashir R; Hochberg FH; Linggood RM; Hottleman K
J Neurosurg; 1988 Jun; 68(6):917-9. PubMed ID: 2836567
[TBL] [Abstract][Full Text] [Related]
3. Intracarotid BCNU leukoencephalopathy.
Kleinschmidt-DeMasters BK
Cancer; 1986 Apr; 57(7):1276-80. PubMed ID: 3948112
[TBL] [Abstract][Full Text] [Related]
4. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
[TBL] [Abstract][Full Text] [Related]
5. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers.
Gutenberg A; Bock HC; Brück W; Doerner L; Mehdorn HM; Roggendorf W; Westphal M; Felsberg J; Reifenberger G; Giese A
Br J Neurosurg; 2013 Dec; 27(6):772-8. PubMed ID: 23662801
[TBL] [Abstract][Full Text] [Related]
6. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: a follow-up study.
West CR; Avellanosa AM; Barua NR; Patel A; Hong CI
Neurosurgery; 1983 Oct; 13(4):420-6. PubMed ID: 6314173
[TBL] [Abstract][Full Text] [Related]
7. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report.
Safdari H; Mompeon B; Dubois JB; Gros C
Surg Neurol; 1985 Nov; 24(5):490-7. PubMed ID: 4049223
[TBL] [Abstract][Full Text] [Related]
8. Sequential and adjuvant chemotherapy for malignant astrocytoma of the brain.
Kessinger A; Lemon HM; Foley JF
J Surg Oncol; 1978; 10(6):543-7. PubMed ID: 215846
[TBL] [Abstract][Full Text] [Related]
9. Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas.
Bradac GB; Soffietti R; Riva A; Stura G; Sales S; Schiffer D
Neuroradiology; 1992; 34(1):73-6. PubMed ID: 1313161
[TBL] [Abstract][Full Text] [Related]
10. Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea.
Kurpad SN; Dolan ME; McLendon RE; Archer GE; Moschel RC; Pegg AE; Bigner DD; Friedman HS
Cancer Chemother Pharmacol; 1997; 39(4):307-16. PubMed ID: 9025771
[TBL] [Abstract][Full Text] [Related]
11. Brain necroses after intraarterial chemotherapy and irradiation of malignant gliomas--a complication of both ACNU and BCNU?
Tonn JC; Roosen K; Schachenmayr W
J Neurooncol; 1991 Dec; 11(3):241-2. PubMed ID: 1823343
[No Abstract] [Full Text] [Related]
12. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
Raizer JJ; Malkin MG; Kleber M; Abrey LE
Neuro Oncol; 2004 Jul; 6(3):247-52. PubMed ID: 15279717
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma.
Liau CT; Wei KC; Tseng CK; Jung SM
Chang Gung Med J; 2005 Jan; 28(1):16-23. PubMed ID: 15804144
[TBL] [Abstract][Full Text] [Related]
14. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
Rajkumar SV; Buckner JC; Schomberg PJ; Pitot HC; Ingle JN; Cascino TL
Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965
[TBL] [Abstract][Full Text] [Related]
15. Superselective arterial BCNU infusion in the treatment of patients with malignant gliomas.
Clayman DA; Wolpert SM; Heros DO
AJNR Am J Neuroradiol; 1989; 10(4):767-71. PubMed ID: 2549772
[TBL] [Abstract][Full Text] [Related]
16. The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma.
Hochberg FH; Pruitt AA; Beck DO; DeBrun G; Davis K
J Neurosurg; 1985 Dec; 63(6):876-80. PubMed ID: 2997415
[TBL] [Abstract][Full Text] [Related]
17. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.
Shapiro WR; Green SB; Burger PC; Selker RG; VanGilder JC; Robertson JT; Mealey J; Ransohff J; Mahaley MS
J Neurosurg; 1992 May; 76(5):772-81. PubMed ID: 1564540
[TBL] [Abstract][Full Text] [Related]
18. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.
Johnson DB; Thompson JM; Corwin JA; Mosley KR; Smith MT; de los Reyes RA; Daly MB; Petty AM; Lamaster D; Pierson WP
J Clin Oncol; 1987 May; 5(5):783-9. PubMed ID: 3553437
[TBL] [Abstract][Full Text] [Related]
19. Safety and Effectiveness of Bis-Chloroethylnitrosourea Wafer Chemotherapy in Elderly Patients with Recurrent Glioblastoma.
Klein J; Juratli TA; Radev Y; Daubner D; Soucek S; Schackert G; Krex D
Oncology; 2017; 93(1):43-50. PubMed ID: 28395288
[TBL] [Abstract][Full Text] [Related]
20. Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors.
Stewart DJ; Grahovac Z; Benoit B; Addison D; Richard MT; Dennery J; Hugenholtz H; Russell N; Peterson E; Maroun JA
Neurosurgery; 1984 Dec; 15(6):828-33. PubMed ID: 6392925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
